1Yeun JY,Levine RA,Mantadilok V. C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients[J].American Journal of Kidney Diseases,2000.469-476.
2Calo LA,Bertipaglia L,Pagnin E. Antioxidants,carnitine and erythropoietin[J].G Ital Nefrol,2006.47-50.
3Ridker PM,Rifain N,Rose L. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events[J].New England Journal of Medicine,2002,(20):1557-1565.doi:10.1056/NEJMoa021993.
4Bellinghieri G,Santoro D,Calvani M. Carnitine and hemodialysis[J].American Journal of Kidney Diseases,2003.116-122.
5Calvani M,Benatti P,Mancinelli A. Camitine replacement in end-stage renai disease andhemodialysis[J].Annals of the New York Academy of Sciences,2004.52-66.
2Caglark, Hakim KM, Ikizler TA. Approaches to the reversal of malnutri- on, Inflammation, and atherosclerosis in end-stage renal disease. Nutr Rev ,2002,60:378-387.
3Stenvinkel P. Inflammatory and atherosclerotic interactions in the depleted uremic patient. Blood Purif,2001,19:53-61.
4Winchester JF. Sorbent hemoperfusion in end-stage renal disease : an in- depth review. Adv Ren Replace Ther,2002 ,9 :19-25.
5Menaa C, Easer E, Sprague SM. Beta 2-macroglobulin stimulates Osteo- blast formation. Kidney int ,2008,73 : 1275-1281.
6Pertosa G, Grandaliano G, Gesualdo L, et al. Clinical relevance of cyto- kine production in hemodialysis. Kid Int,2000,58:76-104.
7pminflammatory role for IL-18 in rheumatoid arthritis. J Clin Invest, 1999,104 : 1393.
8Filiopoulos V, Hadjiyannakos D, Metaxaki P, et al. Inflammation and oxi- dative stress in patients on hemodiafiltration. Am J Nephrol, 2008,28: 949 -957.
9Sch:mig M, Eisenhandt A, Ritz E. The microinflammatory state of uremia[J]. Blood Purif, 2000,18(4):327-332.
10Ramirez R, Martin-Malo A, Aljama P. Inflammation and hemodiafihration[ J ]. Contrib Nephrol, 2007,158(5 ) : 210-215.
